Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
Congress Cuts Funding For State ADAP Programs

The failure of a US Senate spending bill to include $35 million in funding for HIV medications will jeopardize the ability of state AIDS Drug Assistance Programs to offer prescription drugs to nearly 8,000 low-income people living with the virus, according to patient advocates.

Published
17 hours ago
From
Pharmalot
Sluggish response risks squandering historic opportunity to tackle global drug-resistant tuberculosis

If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly stepped up, including addressing barriers that prevent both research into better drug combinations and treatment scale up, MDR-TB rates will continue to increase worldwide and a historic opportunity to improve abysmal cure rates will have been squandered, medical humanitarian organisation Médecins Sans Frontières (MSF) warned today.

Published
20 March 2013
From
MSF
Athens urged to import generic drugs

Public health advocates are petitioning the Greek government to overturn patent protection on costly medicines and import them from low-cost generic producers to ease the burden on the country’s medical system.

Published
18 March 2013
From
Financial Times
Global Drug Facility achieves price reduction for drug-resistant TB treatments

The Stop TB Partnership’s Global Drug Facility has reduced the price of several second-line drugs it supplies for the treatment of multidrug resistant tuberculosis (MDR-TB) by up to 26% compared to 2011 prices, resulting in a decrease in the overall cost of treatment.

Published
18 March 2013
From
Stop TB Partnership
GlaxoSmithKline boss says new drugs can be cheaper

The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to the chief executive of GlaxoSmithKline Plc.

Published
18 March 2013
From
Reuters
Are we underestimating the proportion of virally-suppressed patients in the US?

Several presentations at the recent 20th Conference on Retroviruses and Opportunistic Infections in Atlanta suggest that previous estimates of the proportion of people with HIV in the

Published
15 March 2013
By
Gus Cairns
Uganda government under pressure to boost ARV funding

The Ugandan government's draft 2013/2014 budget allocates US$38.5 million to enrol a further 100,000 people living with HIV on life-prolonging antiretroviral (ARV) drugs. But activists say the money, while welcome in a country still largely dependent on donor funds for its HIV programmes, is not sufficient to meet treatment needs.

Published
15 March 2013
From
IRIN Plus News
Health Canada rejects tesamorelin for lipodystrophy

After consideration of the NDS, Health Canada decided that the risks of tesamorelin outweighed its benefits under the proposed conditions of use.

Published
13 March 2013
From
Theratechnologies press release
Third-line ARVs could widen treatment gap in Zimbabwe

HIV/AIDS activists in Zimbabwe have welcomed the government's move to address the problem of HIV drug resistance by introducing third-line antiretroviral drug (ARVs). But it remains unclear how the cash-strapped government will finance this, as procuring the drugs will invariably be expensive and could divert resources away from other HIV treatment efforts.

Published
12 March 2013
From
IRIN Plus News
West Virginia Advances Bill to Charge for HIV Testing

With pressure from lessening federal funds driving their actions, the West Virginia Senate pushed forward a bill on March 7 that would allow local health departments to charge individuals fees for STD testing.

Published
12 March 2013
From
CDC National Prevention Information Network
← First12345...46Next →

Filter by country